Do flaxseeds lower blood pressure? Updated summary of research

Initial note: This article was previously published and has been updated according to scientific and informative criteria. The text is for informational purposes only and does not replace the advice of your doctor.

IN BRIEF

• Flaxseed (linum usitatissimum) contains ALA (alpha-linolenic acid), lignans, and fiber; some clinical studies show reductions in blood pressure with daily use of ground seeds.
• In controlled trials on patients with cardiovascular risk factors, the observed average reduction in blood pressure is modest but clinically relevant in some subgroups.
• The form (whole vs. ground seeds vs. oil), dose, and duration influence the effects; the best evidence concerns the use of ground seeds at doses around 20–30 g/day for at least 8–12 weeks.
• Plausible biological mechanisms exist (ALA, lignans, effect on the oxylipin pathway and inflammation), but the evidence does not allow for replacing pharmacological therapies when necessary.

Abstract: what does science say?

Flaxseeds are a food source rich in plant-based omega-3 fatty acids (ALA), lignans with phenolic activity, and soluble and insoluble fiber. Randomized clinical trials and several meta-analyses indicate that dietary supplementation with ground flaxseed can reduce systolic and diastolic blood pressure in some groups, particularly in people with hypertension or cardiovascular risk factors. The average magnitude of reduction varies: some reviews show modest average decreases (a few mmHg units), while targeted trials on hypertensive subjects have reported larger reductions. The effect depends on the form of consumption (ground seeds appear more effective than oil or extracts), the dose (clearer effects around 20–30 g/day), and the duration (more consistent effects after ≥8–12 weeks). Plausible mechanisms include oxylipin modulation by ALA, anti-inflammatory effects, and improved metabolic profile. However, much evidence comes from studies with methodological heterogeneity: small sample sizes, specific populations (e.g., peripheral arterial disease), and co-interventions. For this reason, interpretation requires caution: the results support the plausibility of a blood pressure benefit associated with flaxseed consumption but not the replacement of pharmacological therapies; larger, independent trials with designs that isolate the effect of the seed in general populations are needed.

What are flaxseeds and which components are relevant for blood pressure?

Flaxseeds (Linum usitatissimum) are a food source known for three main components that affect cardiovascular health: alpha-linolenic acid (ALA), a plant-based omega-3 fatty acid; lignans, phytoestrogens with antioxidant and metabolic activity; and a significant amount of soluble and insoluble fiber. ALA is a biological precursor to lipid molecules (oxylipins) that modulate vascular tone and inflammation; lignans can influence estrogen metabolism and possess antioxidant activity; fiber helps improve the metabolic profile and satiety. Bioavailability depends on the form of consumption: whole seeds can pass through the digestive system almost intact and release fewer active ingredients than ground seeds; oil concentrates fatty acids but does not contain the fibrous matrix or lignans to the same extent. For this reason, most clinical trials that have observed effects on blood pressure have used ground seeds or flaxseed meal and not simply oil or whole seeds.

Form of consumption and bioavailability

Consuming ground flaxseed ensures better availability of ALA and lignans compared to whole seeds, which often pass through the intestine undigested. Flaxseed oil provides concentrated ALA but loses some of the fiber and matrix that could contribute to the overall effects. In clinical literature, many of the most consistent blood pressure reductions have been observed with ground seeds at standardized doses (e.g., 20–30 g/day), for durations ranging from 8 weeks to 6 months. The choice of form also affects the tolerability profile and integration into the daily diet.

Clinical evidence: what have trials and meta-analyses shown?

Over the past ten to fifteen years, both controlled clinical trials and systematic reviews with meta-analyses have been published evaluating the effect of flaxseed on blood pressure. A randomized trial conducted on patients with peripheral arterial disease using 30 g/day of ground flaxseed observed average reductions in systolic and diastolic blood pressure of several mmHg compared to control, especially in participants who were hypertensive at the start of the study [1]. Subsequent systematic reviews and meta-analyses have synthesized these results, showing an average reduction in systolic and diastolic blood pressure that varies depending on the sample, duration, and form administered: some meta-analyses suggest modest but statistically significant decreases, while others highlight a more pronounced effect in subgroups with hypertension or with consumption of whole/ground seeds [2][3][4]. Overall, the synthesis of evidence supports a favorable blood pressure effect associated with flaxseed consumption, especially when the seed is consumed ground, at adequate doses, and for periods of at least 8–12 weeks. However, differences between studies and a certain degree of methodological heterogeneity remain, requiring cautious interpretation [2][3].

Main results of clinical trials

Some trials on cardiovascular risk populations have reported reductions in systolic blood pressure between 5 and 15 mmHg in subgroups with hypertension, while studies conducted on normotensive subjects show minor or no effects [1][7]. The most up-to-date meta-analyses, which aggregate dozens of trials, estimate an average reduction in systolic blood pressure of 2–5 mmHg and diastolic blood pressure of 1–3 mmHg, with more pronounced effects in hypertensive patients and with higher doses of ground seed [3][4][7]. These variations depend on study size, intervention duration, and control of antihypertensive medications in participants.

Plausible biological mechanisms: why flaxseed might lower blood pressure

Several biological mechanisms have been proposed to explain the potentially antihypertensive effect of flaxseed. ALA can be metabolized into oxylipins that regulate vascular tone; some studies indicate that ALA can inhibit the soluble epoxide hydrolase enzyme, reducing vasoconstrictive metabolites and promoting vasodilation [1][5]. Lignans (e.g., secoisolariciresinol diglucoside) have antioxidant and anti-inflammatory properties that can contribute to endothelial protection. Flaxseed fiber can reduce lipid absorption and modulate glycemic response, with indirect benefits on blood pressure. Furthermore, the combined effect on cholesterol, inflammation, and insulin resistance can reduce the metabolic component that promotes hypertension. It is important to remember that these mechanisms are plausible and supported by experimental and laboratory data, but their relative importance in humans remains to be defined with larger mechanistic studies [5][8].

Mechanistic evidence and limitations

Experimental studies and biomarker analyses in some clinical trials have documented changes in plasma composition of ALA, lignans, and oxylipin profiles associated with flaxseed consumption; these changes are correlated, in some cases, with the observed blood pressure reduction [1][5]. However, mechanistic evidence is still partial: not all studies measure the same biomarkers, and often the sample size is small, so the complete causal chain between consumption, biochemical changes, and blood pressure reduction remains to be consolidated.

Safety, forms of consumption, and studied doses

In clinical trials, the consumption of ground flaxseed at doses around 20–30 g/day is generally well tolerated; reported adverse effects are mostly mild (abdominal bloating, changes in bowel transit). Whole seeds have poor absorption if not ground; oil concentrates ALA but does not contain lignans or fiber to the same extent. People taking anticoagulants or anticoagulant/antiplatelet drugs should consult their doctor before significantly increasing ALA or lignan intake due to the potential, albeit modest, for interaction with coagulation. In trials, most participants continued standard pharmacological therapies, and flaxseed was evaluated as an adjuvant; replacing medications with dietary remedies is not recommended without medical monitoring. Effective doses observed in studies vary, but 20–30 g/day of ground seed is the most studied range and associated with measurable effects on blood pressure in at-risk populations [1][2][7].

Practical safety guidelines

For those wishing to incorporate flaxseed: use ground seeds or flaxseed meal, do not exceed high doses without medical consultation, store ground seeds away from oxidation (in the refrigerator and in a closed container), and inform your doctor if you are on anticoagulant therapy or experience sudden changes in blood pressure. For individuals with allergies or particular gastrointestinal conditions, professional consultation is advisable before regular use.

What it means in practice

For the citizen interested in cardiovascular prevention, current evidence suggests that regular inclusion of ground flaxseed in the diet can be part of a comprehensive approach (balanced diet, physical activity, salt and weight control) aimed at improving cardiovascular risk factors. The effect on blood pressure is not uniform for everyone: those who already have hypertension or other risk factors may experience more noticeable benefits than normotensive subjects. Practical implementation tends to favor 1–2 tablespoons per day (approximately 10–20 g) or up to 30 g/day in studied contexts, mixed with yogurt, cereals, or smoothies, always preferring ground seeds for bioavailability reasons. It is prudent to integrate consumption within the context of a controlled diet and a medical plan when therapies are ongoing: flaxseed can be a complement but not a replacement for prescribed antihypertensive pharmacological therapies. Before modifying medications or initiating high doses, it is necessary to consult your doctor.

Key takeaways

• Flaxseeds contain ALA, lignans, and fiber; the most studied form is ground seeds.
• Controlled trials and meta-analyses show blood pressure reductions, modest on average but potentially relevant in hypertensive subjects. [1][2][3]
• Dose and duration influence effects: more evident effects with 20–30 g/day and interventions ≥8–12 weeks. [1][4]
• Plausible mechanisms include oxylipin modulation by ALA, antioxidant activity of lignans, and metabolic effects. [1][5]
• Do not discontinue antihypertensive medications: flaxseed is a complement, not an automatic alternative.

Limitations of the evidence

It is important to distinguish between association, biological plausibility, observational data, and robust causal evidence. Many studies are randomized but have relatively small sample sizes or selected populations (e.g., patients with peripheral arterial disease), which reduces generalizability. Meta-analyses show heterogeneity among trials in terms of dose, seed form, duration, and population characteristics. Some studies do not rigorously control for concomitant pharmacological therapy or overall dietary changes. Consequently, while consistent signals of benefit exist, the strength of the evidence is not such as to assert definitive causality in all contexts: larger, preregistered trials with diverse populations and long-term clinical endpoints are needed. Furthermore, mechanistic effects, though plausible, are not yet fully elucidated in large-scale, independent human studies. Interpretation must therefore remain cautious and contextualized.

Editorial conclusion

Available scientific evidence supports the hypothesis that regular consumption of ground flaxseed may contribute to reducing blood pressure in some groups of people, particularly in the presence of hypertension or cardiovascular risk factors. The effect is clinically interesting but variable and depends on dose, form, and duration. Flaxseed can be considered a useful nutritional complement within a preventive and therapeutic strategy shared with a doctor, but not a substitute for pharmacological therapies when these are indicated. It remains essential to continue research with larger and mechanistic studies to consolidate efficacy estimates and define practical recommendations based on robust evidence.

Editorial note

This update has been prepared following criteria of transparency, reliability, and referencing. The article summarizes published evidence and provides verifiable references for further reading. The content is for informational purposes only and does not replace personalized medical advice.

Scientific research

1. Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an α‑linolenic acid‑induced inhibition of soluble epoxide hydrolase. Hypertension. 2014;64(1):53–59. https://doi.org/10.1161/HYPERTENSIONAHA.114.03179
2. Flaxseed Consumption May Reduce Blood Pressure: A Systematic Review and Meta‑Analysis of Controlled Trials. J Nutr. 2015;145(4):758–765. https://doi.org/10.3945/jn.114.205302
3. Effects of flaxseed supplements on blood pressure: A systematic review and meta‑analysis of controlled clinical trials. Clin Nutr. 2015. https://doi.org/10.1016/j.clnu.2015.05.012
4. Effect of flaxseed supplementation on blood pressure: a systematic review and dose–response meta‑analysis of randomized clinical trials. Food Funct. 2023. https://doi.org/10.1039/D2FO02566C
5. Dietary flaxseed: Cardiometabolic benefits and its role in promoting healthy aging. Nutrients. 2019;11(5):1171. https://doi.org/10.3390/nu11051171
6. The HYPERFlax trial protocol: study protocol for a randomized, double‑blinded, controlled clinical trial. Trials. 2014;15:232. https://doi.org/10.1186/1745-6215-15-232
7. Impact of weight loss diet associated with flaxseed on inflammatory markers in men with cardiovascular risk factors. Nutr J. 2015;14:5. https://doi.org/10.1186/1475-2891-14-5
8. Flaxseed oil fraction reverses cardiac remodeling at a molecular level: improves cardiac function and decreases apoptosis. BMC Complement Med Ther. 2024;24:6. https://doi.org/10.1186/s12906-023-04319-8

If some original references cited in the historical article are not covered in detail here, the primary works and most recent available reviews have been verified and integrated. For personal clinical information, consult your doctor.